Company news

Assertio Holdings, Inc. news in 2025

Assertio Holdings, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split

December 22, 2025

Assertio Reports Third Quarter 2025 Financial Results

November 10, 2025

Assertio Announces Leadership Transition

October 28, 2025

Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

September 15, 2025

Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association

September 10, 2025

Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025

September 3, 2025

Assertio Reports Second Quarter 2025 Financial Results

August 11, 2025

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025

August 5, 2025

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025

May 19, 2025

Assertio Reports First Quarter 2025 Financial Results

May 12, 2025

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025

May 5, 2025

Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025

March 20, 2025

Assertio Reports Fourth Quarter and Full Year 2024 Financial Results

March 12, 2025

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

March 5, 2025

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

January 2, 2025

Calls in 2025

Decks in 2025